Product Information
OSELTAMIVIR PHOS 75 MG CAPSULE is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.7962 per EA under NDC 76282070445. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Oct 3, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282070445
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA217467FDA Approved
10/3/2023
TE Code
AB
On Market Since
12/1/2023
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7962 per EA |
|---|---|
| All-time high | $1.3763 (Apr 10, 2024) |
| All-time low | $0.7575 (Nov 20, 2024) |
| 52-week high | $0.9163 |
| 52-week low | $0.7962 |
| Median price | $0.9934 |
| Average price | $0.9908 |
| Largest weekly change | -25.2% (Nov 20, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
OSELTAMIVIR PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 75 MG CAPSULE, manufactured by Exelan Pharmaceuticals Inc., is $0.7962 per EA (NDC 76282070445), effective Sep 30, 2026.
How has the price of OSELTAMIVIR PHOS 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has declined 42.1%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 75 MG CAPSULE?
Since Apr 10, 2024, the NADAC for OSELTAMIVIR PHOS 75 MG CAPSULE has ranged from a low of $0.7575 (Nov 20, 2024) to a high of $1.3763 (Apr 10, 2024), with a median of $0.9934 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 75 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR PHOS 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 75 MG CAPSULE?
OSELTAMIVIR PHOS 75 MG CAPSULE (NDC 76282070445) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.